期刊文献+

5-氨基水杨酸锌结肠定位肠溶胶囊在人体内的转运释放和吸收 被引量:3

Transport release and absorption of zinc 5-aminosalicylate colon targeting capsules in human
原文传递
导出
摘要 目的观察5-氨基水杨酸锌结肠定位肠溶胶囊的体内转运释放和吸收特征。方法健康受试者和轻、中度溃疡性结肠炎患者各10例,定时X线拍片观察胶囊在体内的位置和溶解情况;同时检测血浆5-氨基水杨酸(5-ASA)和乙酰-5-氨基水杨酸(AC-5-ASA)及锌离子浓度。结果 10例健康受试者:胶囊到达升结肠的平均时间为(5.80±1.99)h,胶囊崩解平均时间为(8.00±1.63)h。10例患者:胶囊到达升结肠的平均时间为(6.80±3.65)h,崩解的平均时间为(9.75±2.50)h。9例健康受试者:口服5-氨基水杨酸锌1.0 g,5-ASA主要参数Tmax为(12.33±1.73)h,Cmax为(325.72±197.52)μg.L-1,AUC0→t为(3.66±2.26)mg.L-1.h;排泄总量:5-ASA为(94.4842±61.3647)mg,AC-5-ASA为(120.4207±78.2098)mg,经尿液排泄的5-ASA约为剂量的9.4%。8例患者:口服5-氨基水杨酸锌1.0 g,5-ASA主要参数Tmax为(11.38±5.72)h,Cmax为(235.83±177.90)μg.L-1,AUC0→t为(3.19±1.58)mg.L-1.h。结论 5-氨基水杨酸锌结肠定位肠溶胶囊能在溃疡性结肠炎患者及健康受试者结肠定位释药,两者释放特征、吸收情况相近。 Objective To investigate the transport, release and absorption characteristics of zinc 5 - aminosalicylate colon targeting capsules in human. Methods A single oral dose of 1.0 g zinc 5 - aminosalicylate colon targeting capsules was administered to 10 healthy volunteers or 10 patients with mild or moderate ulcerative colitis. The position and dissolution of the capsules was observed with X - ray at different time points, and the concentration of 5 -aminosalicylic acid(5 -ASA) , acetyl -5 - aminosalicylic acid (AC -5 -ASA ), and Zn2+ in plasma were determined. Results The time that the capsules reached ascending colon and disintegrated in healthy volunteers was ( 5.80 ± 1.99 ), ( 8.00 ± 1.63 ) h ; in patients the time was(6.80 ±3.65), (9.75 ±2.50)h. The pharmacokinetic parameters of 5 - ASA in healthy volunteers ( n = 9 ) and patients ( n = 8 ) were as follows : Tmax was ( 12. 33 ± 1.73 ), ( 11.38 ± 5.72) h, respectively; Cmax was (325.72 ± 197.52), (325.72 ± 197.52) ug . L-1, respectively; AUC0-t was(3.66 ±2.26), (3.19 ± 1.58)mg . L-1 . h, respectively. The cumulative excretion percentage of 5 -ASA was about 9.4% in urine. Conclusion It was shown that the zinc 5 - aminosalicylate colon targetingcapsules were released in the colon, and the release and absorption were similar in the healthy volunteers and the patients groups.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第1期18-21,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家火炬计划基金资助项目(2005EB021255)
关键词 5-氨基水杨酸锌结肠定位胶囊 转运 释放 吸收 zinc 5 - aminosalicylate colon targeting capsule transport release absorption
  • 相关文献

参考文献9

  • 1Sandborn W J,Hanauer SB,Buch A. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine(Asacol)and balsalazide:a randomized,single-dose,crossover study inhealthy volunteers[J].Alimentary Pharmacology and Therapeutics,2004.1089-1098.
  • 2Brunner M,Greinwald R,Kletter K. Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs.tablets in male healthy volunteers[J].Alimentary Pharmacology and Therapeutics,2003.1163-1169.
  • 3Edsbacker S,Bengtsson B,Larsson P. A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort)capsules[J].Alimentary Pharmacology and Therapeutics,2003.525-536.
  • 4Schr(o)der H,Campbell DES. Absorption,metabolism and excretion of salicylazosulfapyridine in man[J].Clinical Pharmacology and Therapeutics,1972.539-551.
  • 5Brogden RN,Sorkin EM. Mesalazine:A review of its pharmacodynamic and pharmacokinetic properties,and therapeutic potential in chronic inflammatory bewel disease[J].Drugs,1989.500-523.
  • 6Swift GL,Mills CM. A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine[J].Alimentary Pharmacology and Therapeutics,1992.259-266.
  • 7龙启才,赵香兰,曾桂雄,陆志城,蔡杏春.国产美沙拉嗪的Ⅰ期临床试验研究[J].中国临床药理学杂志,1996,12(4):215-223. 被引量:7
  • 8陆志城,蔡杏春,刘文坚.反相高效液相色谱法测定5-氨基水杨酸及其代谢物在人血浆及尿中的浓度[J].中国医院药学杂志,1998,18(6):248-250. 被引量:1
  • 9Yilmaz ME,Kiraz M,Kara IH. The evaluation of serum zinc and copper levels in hemodialysis patients in southeast Turkey[J].Dialysis & Transplantation,2000.718-720.

二级参考文献6

  • 1Klotz U and Maier KE. Pharmacology and Pharmacokinetics of 5-Aminosalicylic Acid, Digestive Diseases and Sciences, 1987.32(12) : 46-50.
  • 2Dale K. Yu,Alfred T. Elvin, Bruce Morrill, et al. Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability. Clin Pharmacol Ther, 1990,48 - 26.
  • 3Klotz U and Stracciari GL. Steady State Disposition of 5-aminosallcylie acid following oral dosing. Arzneim Forseh/Drug Res, 1993,43(1) ,No12: 1357-1359.
  • 4Rasmussen SN, Bondesen S, Hvidberg EF, et al . 5-aminoalicylic acid in a slow-release preparation: bioavailability ,Plasma Level ,and Excretion in Humans, Gastroenterology, 1982,83:1062-1070.
  • 5De Vos M, Verdievel H,Schoonjans T, et al .High performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans. J Chromatogr ,1991,564:296-302.
  • 6Hansen SH. Assay o5 5-aminosalicylate and its acetylated metabolite in biological fluids by high performance liquid chromatography on dynamically modified silica, J Chromatogr, 1981,226 :504- 509.

共引文献6

同被引文献45

  • 1王乐,任麒,沈慧凤.时间控制型结肠定位释药片体外释放的影响因素[J].中国医药工业杂志,2006,37(5):325-328. 被引量:3
  • 2MACKAY M, THOMLINSON E. Colonic delivery of therapeutic peptides and proteins[ A]. In: Bieck P Red Colonic drug absorp- tion and meta bolism[ M]. New York, 1993:159 -176.
  • 3KARROUT Y, NEUT C, WILS D, et al. Novel polymeric film coatings for colon targeting: drug release from coated pellets[ J]. Eur J Pharm Sci,2009,37 ( 3 - 4 ) :427 - 433.
  • 4XIAO MM,ZHANG SQ,WANG XY, et al. Study on the charac- teristics of pectin-ketoprofen for clon targeting in rats [ J ]. Int J Pharm,2005,298 ( 1 ) :91 - 97.
  • 5PERERA G, BARTHELMES J, BERNKOP-SCHNURCH A. Novelpectin-4-aminothio phenole conjugate microparticles for co- lon-spe-cific drug delivery [ J]. J Control Rel, 2010, 145 ( 3 ) : 240 - 246.
  • 6WONG D, LARRABEE S, CLIFFORD K,et al. USP Dissolution apparatus III ( reciprocating cylinder) for screening of guar-based colonic delivery formulations [ J ]. J Control Rcl, 1997,47 ( 3 ) : 173 - 179.
  • 7SINGH AK, PATHAK K. Colon specific CODES based Piroxi- cam tablet for colon targeting: statistical optimization, in vivoro- entgenography and stability[ J]. Pharm Dev Technol, 2013, Nov 25. [Epub ahead of print].
  • 8FREIRE C, PODCZECK F, VEIGA F,et al. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high- amylose starch and Surelease intended for colon-specific drug de- livery[ J ]. Drug Dev Ind Pharm, 2010,36 ( 2 ) : 161 - 172.
  • 9RUBINSTEIN A, RADAI R, EZNA M,et al. In vitro evaluation of calcium peetinate : a potential colon-specific drug delivery ear-rier[J]. Pharm Res,1993 ,10( 2 ) :258 - 263.
  • 10YANG L. Bio-relcvant dissolution testing of colon-specific de/iv- cry system activated by colonic microflora [ J ]. Control Rel,2008, 125(2) :77 -86.

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部